Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and which is in Phase II clinical trial for treating common warts. It is also developing cantharidin-based product candidate, VP-103 for treating plantar warts. The company has a license and collaboration agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102; and a license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatological oncology indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Verrica Pharmaceuticals Inc..
Verrica Pharmaceuticals Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Verrica Pharmaceuticals Inc. are also analyzed.
Detailed
SWOT Analysis of the company including key strengths and weaknesses of Verrica Pharmaceuticals Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Verrica Pharmaceuticals Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Verrica Pharmaceuticals Inc. and all latest updates of the company are provided.
The 2025 version of Verrica Pharmaceuticals Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Verrica Pharmaceuticals Inc.- Key Facts
2.2 Verrica Pharmaceuticals Inc.- Geographic Locations
2.3 Verrica Pharmaceuticals Inc.- Subsidiaries and Affiliates
2.4 Verrica Pharmaceuticals Inc.- Business Divisions
2.5 Verrica Pharmaceuticals Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Verrica Pharmaceuticals Inc. Strategic Analysis Review
3.1 Verrica Pharmaceuticals Inc.- Key Strategies
3.2 Verrica Pharmaceuticals Inc.- Company Outlook Statement
3.3 Verrica Pharmaceuticals Inc.- SWOT Analysis
3.3.1 Verrica Pharmaceuticals Inc.- Key Strengths
3.3.2 Verrica Pharmaceuticals Inc.- Key Weaknesses
3.3.3 Verrica Pharmaceuticals Inc.- Potential Opportunities
3.3.4 Verrica Pharmaceuticals Inc.- Potential Threats
3.4 Verrica Pharmaceuticals Inc.- Key Competitors
4. Business Description of the Company
4.1 Verrica Pharmaceuticals Inc.- Business Overview
4.2 Verrica Pharmaceuticals Inc.- Operations by Segment
5 Products and Services Details
5.1 Verrica Pharmaceuticals Inc.- Key Products
5.2 Verrica Pharmaceuticals Inc.- Key Service Areas
5.3 Verrica Pharmaceuticals Inc.- Key Brands
6 Company Developments
6.1 Verrica Pharmaceuticals Inc.- Company History
6.2 Verrica Pharmaceuticals Inc.- Latest Developments
7 Financial Analysis
7.1 Verrica Pharmaceuticals Inc.- Income Statements
7.2 Verrica Pharmaceuticals Inc.- Balance Sheet
7.3 Verrica Pharmaceuticals Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Verrica Pharmaceuticals Inc.- Direct Competitors
8.2 Verrica Pharmaceuticals Inc.- Competitor Financial Ratios comparison
8.3 Verrica Pharmaceuticals Inc.- Competitor Stock Charts Comparison
8.4 Verrica Pharmaceuticals Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
